- Home
- ZLAB vs IPAR Comparison
ZLAB vs IPAR Comparison
Compare ZLAB & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- IPAR
- Stock Information
- Founded
- ZLAB 2013
- IPAR 1982
- Country
- ZLAB China
- IPAR United States
- Employees
- ZLAB N/A
- IPAR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- IPAR Package Goods/Cosmetics
- Sector
- ZLAB Health Care
- IPAR Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- IPAR Nasdaq
- Market Cap
- ZLAB 3.6B
- IPAR 4.2B
- IPO Year
- ZLAB 2017
- IPAR 1988
- Fundamental
- Price
- ZLAB $32.54
- IPAR $135.50
- Analyst Decision
- ZLAB Buy
- IPAR Strong Buy
- Analyst Count
- ZLAB 5
- IPAR 5
- Target Price
- ZLAB $54.28
- IPAR $157.60
- AVG Volume (30 Days)
- ZLAB 781.8K
- IPAR 199.0K
- Earning Date
- ZLAB 08-05-2025
- IPAR 08-05-2025
- Dividend Yield
- ZLAB N/A
- IPAR 2.36%
- EPS Growth
- ZLAB N/A
- IPAR 19.12
- EPS
- ZLAB N/A
- IPAR 5.17
- Revenue
- ZLAB $418,326,000.00
- IPAR $1,467,181,000.00
- Revenue This Year
- ZLAB $44.07
- IPAR $5.90
- Revenue Next Year
- ZLAB $49.13
- IPAR $3.25
- P/E Ratio
- ZLAB N/A
- IPAR $26.24
- Revenue Growth
- ZLAB 43.72
- IPAR 10.32
- 52 Week Low
- ZLAB $16.01
- IPAR $97.65
- 52 Week High
- ZLAB $44.34
- IPAR $148.15
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- IPAR 53.80
- Support Level
- ZLAB $34.26
- IPAR $133.65
- Resistance Level
- ZLAB $35.72
- IPAR $139.00
- Average True Range (ATR)
- ZLAB 1.12
- IPAR 3.40
- MACD
- ZLAB -0.54
- IPAR -0.28
- Stochastic Oscillator
- ZLAB 3.83
- IPAR 54.13
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.